Covered recipient · General Payments record
DAVID BROOMALL
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2023
$1,433.32
- Reported across 85 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $244.95 | 11 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Incyte Corporation | $83.29 | 4 |
| Almirall LLC | $68.07 | 3 |
| Amgen Inc. | $29.62 | 1 |
| ABBVIE INC. | $23.90 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $21.17 | 1 |
| Regeneron Healthcare Solutions, Inc. | $18.90 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $23.90 | 03/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996311521 | CMS |
| Almirall LLC | $23.75 | 03/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1038191801 | CMS |
| Almirall LLC | $20.04 | 06/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1038191703 | CMS |
| Almirall LLC | $24.28 | 09/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1038191887 | CMS |
| Amgen Inc. | $29.62 | 07/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020565209 | CMS |
| Incyte Corporation | $27.07 | 02/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1044410263 | CMS |
| Incyte Corporation | $18.32 | 04/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1044410283 | CMS |
| Incyte Corporation | $23.19 | 07/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1044410325 | CMS |
| Incyte Corporation | $14.71 | 10/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1044410343 | CMS |
| Regeneron Healthcare Solutions, Inc. | $18.90 | 02/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999105309 | CMS |
| Sun Pharmaceutical Industries Inc. | $21.17 | 06/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1053828017 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.